Nitric oxide donor-induced p53-sensitive cell death is enhanced by Bcl-2 reduction in human neuroblastoma cells

Neurochemistry International

Volumn 32, Issue 1, 1998, Pages 93-102

  Kitamura, Yoshihisa ^a   Kamoshima, Wataru ^a   Shimohama, Shun ^b   Nomura, Yasuyuki ^c   Taniguchi, Takashi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; DNA FRAGMENT; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; STAUROSPORINE;

APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DEGRADATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NUCLEOSOME; PRIORITY JOURNAL;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BUCLADESINE; CELL DEATH; DIMERIZATION; DNA FRAGMENTATION; GENE EXPRESSION; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; NEUROBLASTOMA; NITRIC OXIDE; OXIDATION-REDUCTION; PENICILLAMINE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; S-NITROSO-N-ACETYLPENICILLAMINE; STAUROSPORINE; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031985992     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(97)00029-6     Document Type: Article

References (31)

1. Batistatou, A., Merry, D. E., Korsmeyer, S. J., & Greene, L. A. (1993). Bcl-2 affects survival but not neuronal differentiation of PC12 cells. J. Neurosci., 13, 4422-4428.
2. Caelles, C., Helmberg, A., & Karin, M. (1994). p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature, 370, 220-223.
3. Chiou, S.-K., Rao, L., & White, E. (1994). Bcl-2 blocks p53-dependent apoptosis. Mol. Cell Biol., 14, 2556-2563.
4. Davies, A. M. (1995). The Bcl-2 family of proteins, and the regulation of neuronal survival. Trends Neurosci., 18, 355-358.
5. Dawson, T. M., Dawson, V. L., & Snyder, S. H. (1992). A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann. Neurol., 32, 297-311.
6. Dawson, V. L., Dawson, T. M., London, E. D., Bredt, D. S., & Snyder, S. H. (1991). Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl Acad. Sci. U.S.A., 88, 6368-6371.
7. Dimmeler, S., Lottspeich, F., & Brüne, B. (1992). Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem., 267, 16771-16774.
8. Garcia, I., Maetinou, I., Tsujimoto, Y., & Martinou, J.-C. (1992). Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science, 258, 302-304.
9. 15N]nitrate in biological fluids. Anal. Biochem., 126, 131-138.
10. Itano, Y., Ito, A., Uehara, T., & Nomura, Y. (1996). Regulation of Bcl-2 protein expression in human neuroblastoma SH-SY5Y cells: Positive and negative effects of protein kinases C and A, respectively. J. Neurochem., 67, 131-137.
11. Kamoshima, W., Kitamura, Y., Nomura, Y., & Taniguchi, T. (1997). Possible involvement of ADP-ribosylation of particular enzymes in cell death induced by nitric oxide-donors in human neuroblastoma cells. Neurochem. Int., 30, 305-311.
12. Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Örd, T., & Bredesen, D. E. (1993). Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science, 262, 1274-1277.
13. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
14. Linnik, M. D., Miller, J. A., Sprinkle-Cavallo, J., Mason, P. J., Thompson, F. Y., Montgomery, L. R., & Schroeder, K. K. (1995). Apoptotic DNA fragmentation in the rat cerebral cortex induced by permanent middle cerebral artery occlusion. Molec. Brain Res., 32, 116-124.
15. Loiacono, R. E., & Beart, P. M. (1992). Hippocampal lesions induced by microinjection of the nitric oxide donor nitroprusside. Eur. J. Pharmac., 216, 331-333.
16. Martinou, J.-C., Dubois-Dauphin, M., Staple, J. K., Rodriguez, I., Frankowski, H., Missotten, M., Albertini, P., Talabot, D., Catsicas, S., Pietra, C., & Huarte, J. (1994). Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron, 13, 1017-1030.
17. Meßmer, U. K., Ankarcrona, M., Nicotera, P. and Brüne, B. (1994). p53 expression in nitric oxide-induced apoptosis. FEBS Lett., 355, 23-26.
18. Meßmer, U. K., Lapetina, E. G., & Brüne, B. (1995). Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C-and protein kinase A-activating compounds. Molec. Pharmac., 47, 757-765.
19. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B., & Reed, J. C. (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and vivo. Oncogene, 9, 1799-1805.
20. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63.
21. Nguyen, T., Brunson, D., Crespi, C. L., Penman, B. W., Wishnok, J. S., & Tannenbaum, S. R. (1992). DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl Acad. Sci. U.S.A., 89, 3030-3034.
22. Oltivai, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death . Cell, 74, 609-619.
23. Reed, J. C., Meister, L., Tanaka, S., Cuddy, M., Yum, S., Geyer, C., & Pleasure, D. (1991). Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res., 51, 6529-6538.
24. Ross, R. A., Spengler, B. A., & Biedler, J. L. (1983). Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl Cancer Inst., 71, 741-747.
25. Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992). Biochemistry of nitric oxide and its redox-activated forms. Science, 258, 1898-1902.
26. Satou, T., Cummings, B. J., & Cotman, C. W. (1995). Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res., 697, 35-43.
27. Strasser, A., Harris, A. W., Jacks, T., & Cory, S. (1994). DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell, 79, 329-339.
28. Stuehr, D. J., & Nathan, C. F. (1989). Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med., 169, 1543-1555.
29. Wang, Y., Szekely, L., Okan, I., Kein, G., & Wiman, K. G. (1993). Wild-type p53-triggered appoptosis is inhibited by bcl-2 in a v-mycinduced T-cell lymphoma line. Oncogene, 8, 3427-3431.
30. 2+ and by rapid desensitization. J. Neurochem., 63, 177-185.
31. Yin, X.-M., Oltvai, Z. N., & Korsmeyer, S. J. (1994). BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature, 369, 321-323.